SCHEMBL22170341

SCHEMBL22170341

N#Cc1ccc(-c2ccc3c4ccc(-c5ccc(C#N)cc5C#N)cc4n(-c4cc(-c5ccncc5)c(-n5c6cc(-c7ccc(C#N)cc7C#N)ccc6c6ccc(-c7ccc(C#N)cc7C#N)cc65)cc4C#N)c3c2)c(C#N)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 2/20 0.40
STS P08842 1/20 0.38
XDH P47989 1/20 0.37
CYP11B1 P15538 2/20 0.36
CYP11B2 P19099 2/20 0.36
PRMT5 O14744 1/20 0.35
WDR77 Q9BQA1 1/20 0.35
CYP19A1 P11511 1/20 0.35
LRRK2 Q5S007 3/20 0.35
PKN1 Q16512 1/20 0.34
PKN2 Q16513 1/20 0.34
GCGR P47871 1/20 0.34
MAPK14 Q16539 1/20 0.34
METAP2 P50579 1/20 0.33
GSK3A P49840 1/20 0.33
GSK3B P49841 1/20 0.33
LMNA P02545 2/20 0.32
MAPT P10636 1/20 0.32
HTT P42858 1/20 0.32
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19909297 0.96 STS (0.38) FLT3STSXDHCYP11B1CYP11B2
SCHEMBL19919623 0.94 FLT3 (0.36) FLT3STSXDHCYP11B1CYP11B2
SCHEMBL19909525 0.93 STS (0.39) FLT3STSXDHCYP11B1CYP11B2
SCHEMBL19909300 0.91 STS (0.38) FLT3STSXDHCYP11B1CYP11B2
SCHEMBL19909085 0.91 FLT3 (0.39) FLT3CYP11B1CYP11B2CYP19A1LRRK2
SCHEMBL20923834 0.90 CYP11B1 (0.40) FLT3STSXDHCYP11B1CYP11B2
SCHEMBL20924092 0.90 CYP19A1 (0.40) FLT3STSXDHCYP11B1CYP11B2
SCHEMBL19909005 0.90 STS (0.38) FLT3STSXDHCYP11B1CYP11B2
SCHEMBL20924122 0.90 FLT3 (0.38) FLT3STSXDHCYP11B1CYP11B2
SCHEMBL20924090 0.90 CYP19A1 (0.38) FLT3STSXDHCYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588114-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-21 US disclosed
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-07-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OPRM1, OR51E2 FLT3 2571/4885STS 2528/4885XDH 483/4885
US-11588114-B2 Organic molecules for use in optoelectronic devices OR10J3, OPRM1, OR51E2 FLT3 2571/4885STS 2528/4885XDH 483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.